InvestorsHub Logo
Followers 317
Posts 22744
Boards Moderated 2
Alias Born 04/26/2019

Re: None

Monday, 08/12/2019 9:40:40 AM

Monday, August 12, 2019 9:40:40 AM

Post# of 118409
RGBP announced recently filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in an efficacious manner while appearing not to induce any form of toxicity.

52-wk high was 0.025 per share. Where is RGBP heading to?

Pennyland and then a nickel. Wait and see!!